Azitra Share Price
AMEX: AZTR | HealthcareAzitra Stock Performance
Azitra Share Price Chart
Azitra Quarterly Profit & Loss
All figures in USD
Azitra Annual Profit & Loss
All figures in USD
Azitra Balance Sheet
All figures in USD Million
Azitra Cash Flow
All figures in USD Million
Corporate Actions
About Azitra
Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.
Azitra Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $0.75 | $0.60 | -23.59% |
Oct 2026 | $0.14 | $0.78 | +482.09% |
Sep 2026 | $0.17 | $0.13 | -28.72% |
Aug 2026 | $0.13 | $0.19 | +42.42% |
Jul 2026 | $0.16 | $0.13 | -19.51% |
Jun 2026 | $0.23 | $0.16 | -28.07% |
May 2026 | $0.25 | $0.23 | -11.28% |
Apr 2026 | $0.23 | $0.26 | +9.36% |
Mar 2026 | $0.17 | $0.23 | +33.52% |
Feb 2026 | $0.25 | $0.18 | -28.46% |
Jan 2026 | $0.28 | $0.25 | -8.55% |
Dec 2025 | $0.36 | $0.27 | -27.88% |